Avisa Diagnostics Stock Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Avisa Diagnostics are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Avisa Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Avisa Diagnostics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Avisa |
Avisa Diagnostics Relative Risk vs. Return Landscape
If you would invest 0.00 in Avisa Diagnostics on November 11, 2025 and sell it today you would earn a total of 0.00 from holding Avisa Diagnostics or generate 0.0% return on investment over 90 days. Avisa Diagnostics is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Avisa, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Avisa Diagnostics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Avisa Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Avisa Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Avisa Diagnostics generated a negative expected return over the last 90 days | |
| Avisa Diagnostics has some characteristics of a very speculative penny stock | |
| Avisa Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Avisa Diagnostics has accumulated 153.44 K in total debt. Avisa Diagnostics has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Avisa Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Avisa Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avisa Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avisa to invest in growth at high rates of return. When we think about Avisa Diagnostics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 277.83 K. Net Loss for the year was (715.76 K) with profit before overhead, payroll, taxes, and interest of 129.28 K. | |
| Avisa Diagnostics has accumulated about 97.6 K in cash with (452.28 K) of positive cash flow from operations. |
Avisa Diagnostics Fundamentals Growth
Avisa Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Avisa Diagnostics, and Avisa Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Avisa Pink Sheet performance.
| Return On Equity | -2.89 | |||
| Return On Asset | -1.41 | |||
| Current Valuation | 9.09 M | |||
| Shares Outstanding | 75.62 M | |||
| Price To Book | 12.76 X | |||
| Price To Sales | 12.69 X | |||
| Revenue | 277.83 K | |||
| EBITDA | (678.64 K) | |||
| Cash And Equivalents | 97.6 K | |||
| Total Debt | 153.44 K | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (452.28 K) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 122.16 K | |||
About Avisa Diagnostics Performance
By analyzing Avisa Diagnostics' fundamental ratios, stakeholders can gain valuable insights into Avisa Diagnostics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Avisa Diagnostics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Avisa Diagnostics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Avisa Diagnostics Inc. operates a clinical-stage medical device company. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics is traded on OTC Exchange in the United States.Things to note about Avisa Diagnostics performance evaluation
Checking the ongoing alerts about Avisa Diagnostics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Avisa Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Avisa Diagnostics generated a negative expected return over the last 90 days | |
| Avisa Diagnostics has some characteristics of a very speculative penny stock | |
| Avisa Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Avisa Diagnostics has accumulated 153.44 K in total debt. Avisa Diagnostics has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Avisa Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Avisa Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avisa Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avisa to invest in growth at high rates of return. When we think about Avisa Diagnostics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 277.83 K. Net Loss for the year was (715.76 K) with profit before overhead, payroll, taxes, and interest of 129.28 K. | |
| Avisa Diagnostics has accumulated about 97.6 K in cash with (452.28 K) of positive cash flow from operations. |
- Analyzing Avisa Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Avisa Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Avisa Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Avisa Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Avisa Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Avisa Diagnostics' pink sheet. These opinions can provide insight into Avisa Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Avisa Pink Sheet analysis
When running Avisa Diagnostics' price analysis, check to measure Avisa Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avisa Diagnostics is operating at the current time. Most of Avisa Diagnostics' value examination focuses on studying past and present price action to predict the probability of Avisa Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avisa Diagnostics' price. Additionally, you may evaluate how the addition of Avisa Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |